{"RecieveEnt":"国药集团药业股份有限公司","PayEnt":"非公开","Money":"RMB71.7亿","Rounds":"上市定增轮","Url":"https://zdb.pedaily.cn/inv/show11248/","Sn":"11248","Title":"国药控股、畅新易达、康辰药业 等投资国药股份39.71%股权","Date":"2017年06月05日","Industry":"生物技术/医疗健康 > 医药"}